{"id":159,"date":"2019-01-29T15:43:43","date_gmt":"2019-01-29T06:43:43","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/?page_id=159"},"modified":"2021-09-15T13:51:49","modified_gmt":"2021-09-15T04:51:49","slug":"publications2017","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/publications\/publications2017\/","title":{"rendered":"2017"},"content":{"rendered":"

\u7dcf\u8aac\u30fb\u8457\u66f8\uff08\u65e5\u672c\u8a9e\uff09<\/h4>\n
    \n
  1. \u6a0b\u7530\u4eac\u5b50<\/span>\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u68ee\u672c\u771f\u5f18\uff1a\u843d\u8c37\u5b5d\u5e83\u76e3\u4fee\uff0c\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\u3092\u3082\u305f\u3089\u3059\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u6a5f\u80fd\u7814\u7a76\u6700\u524d\u7dda\uff0c\u201c\u304c\u3093\u3068\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u201d\uff0c\u30a8\u30cc\u30fb\u30c6\u30a3\u30fc\u30fb\u30a8\u30b9\uff0c127-136, 2017\uff08\u5206\u62c5\u57f7\u7b46\uff09<\/li>\n
  2. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u7cfb\u306e\u7570\u5e38,\u300c\u751f\u4f53\u306e\u79d1\u5b66 \u7279\u96c6 \u8840\u7ba1\u5236\u5fa1\u7cfb\u3068\u75be\u60a3\u300d\u533b\u5b66\u66f8\u9662, 68(4), 321\u2212323, 2017<\/li>\n<\/ol>\n

    \u82f1\u6587\u7dcf\u8aac<\/h4>\n
      \n
    1. *Hida K.<\/u>, Maishi N.\uff1aAbnormalities of tumor endothelial cells and cancer progression,\u00a0Oral Sci Int<\/em><\/strong>, 15(1), 1-6, 2017<\/li>\n
    2. Maishi N.,\u00a0Hida K.<\/u>\uff1aTumor endothelial cells accelerate tumor metastasis,\u00a0Cancer Sci<\/em><\/strong>, 108(10), 1921-1926, 2017<\/li>\n
    3. *Hida K<\/u>., Kikuchi H., Maishi N., Hida Y\uff1aATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy,\u00a0Cancer Lett,<\/em><\/strong>\u00a0400, 305-310, 2017<\/li>\n<\/ol>\n

      \u82f1\u8a9e\u8ad6\u6587<\/strong><\/h4>\n
        \n
      1. Hida K<\/u>.\u00a7<\/strong>, Maishi N.\u00a7<\/strong>, Akiyama K., Ohmura-Kakutani H., Torii C., Ohga N., Osawa T., Kikuchi H., Morimoto H., Morimoto M., Shindoh M., Shinohara N., Hida Y.,\uff1aTumor Endothelial Cells with High Aldehyde Dehydrogenase Activity Show drug resistance,\u00a0Cancer Sci<\/em><\/strong>, 108(11), 2195-2203, 2017<\/li>\n
      2. Hida K.<\/u>\u00a7<\/strong>, Kawamoto T.\u00a7<\/strong>, Maishi N., Morimoto M., Akiyama K., Ohga N., Shindoh M., Shinohara N., Hida Y.\uff1amiR-145 Promoted Anoikis Resistance in Tumor Endothelial Cells,\u00a0J Biochem<\/strong><\/em>, 162(2), 81-84<\/li>\n
      3. Hojo T.\u00a7<\/strong>, Maishi N.\u00a7<\/strong>, Alam Mohammad Towfik, Akiyama K., Ohga N., Shindoh M., Hida Y., Minowa K., Fujisawa T.,\u00a0*Hida K.\uff1a<\/u>ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells,\u00a0Oncotarget,<\/em><\/strong>\u00a08(28), 45484-45495, 2017<\/li>\n
      4. Torii C., Hida Y., Shindoh M., Akiyama K., Ohga N., Maishi N., Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Sato Y.,\u00a0*Hida K<\/u>.\uff1aVasohibin-1 as a novel prognostic factor for head and neck squamous cell carcinoma,\u00a0Anticancer Res<\/em><\/strong>, 37(3), 1219-1225, 2017<\/li>\n
      5. *Hida K.<\/u>, Maishi N., Dorcas Akuba-Muhyia Annan, Kondoh M., Hojo T., Umma Habiba, Ohga N., Ishikawa K, Sato M., Torii C., Yanagiya M., Morimoto M., Hida Y., Shindoh M.\uff1aAneuploidy of murine immortalized endothelial cell line, MS1\uff0cJ Oral Biosci<\/em><\/strong>\uff0c59 (2017), 50-54, 2017<\/li>\n
      6. Habiba U.,\u00a0*Hida K.<\/u>, Kitamura T., Yanagawa Matsuda A., Higashino F., Ito M Y., Ohiro Y., Totsuka Y., Shindoh M.,\uff1a ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia,\u00a0Oncol Lett<\/em><\/strong>, 13(1), 321-328, 2017<\/li>\n<\/ol>\n

        \u62db\u5f85\u8b1b\u6f14<\/h4>\n
          \n
        1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c25\u56de\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000AAVBM2017\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201cTumor Angiogenesis and Lymphangiogenesis\u201d\uff0c\u201cChemotherapy-induced drug resistance in tumor endothelial cells\u201d\uff0c2017.12.10\uff08\u5927\u962a\uff09<\/li>\n
        2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c40\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u751f\u8001\u75c5\u6b7b\u306b\u304a\u3051\u308b\u8840\u7ba1\u30fb\u30ea\u30f3\u30d1\u7ba1\u306e\u751f\u547d\u79d1\u5b66\u7684\u610f\u7fa9\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f62\u8cea\u5909\u5316\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c2017.12.7\uff08\u795e\u6238\uff09<\/li>\n
        3. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c40\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u7d30\u80de\u5916\u5c0f\u80de\u9846\u7c92\u306f\u6211\u3005\u306b\u4f55\u3092\u8a9e\u308b\u304b\uff1f\uff5e\u7d30\u80de\u9593\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u304c\u7e54\u308a\u306a\u3059\u751f\u547d\u73fe\u8c61\u306e\u89e3\u660e\u3078\uff5e\u300d\uff0c\u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760dmiR\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e\u201d\uff0c2017.12.7\uff08\u795e\u6238\uff09<\/li>\n
        4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5e73\u621029\u5e74\u5ea6\u5148\u7aef\u533b\u5b66\u7814\u7a76\u30bb\u30df\u30ca\u30fc\uff08\u672d\u5e4c\u533b\u79d1\u5927\u5b66\uff09\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d2017.11.17\uff08\u672d\u5e4c\uff09<\/li>\n
        5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c62\u56de\u65e5\u672c\u53e3\u8154\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u7279\u5225\u30d7\u30ed\u30b0\u30e9\u30e0\u300c\u65e5\u53f0\u59c9\u59b9\u7de0\u7d5010\u5468\u5e74\u8a18\u5ff5\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000Translational Research\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306b\u95a2\u3059\u308b\u57fa\u790e\u7814\u7a76\u304b\u3089\u65b0\u305f\u306a\u304c\u3093\u6cbb\u7642\u6226\u7565\u306e\u69cb\u7bc9\u3092\u76ee\u6307\u3057\u3066\u201d\uff0c2017.10.21\uff08\u4eac\u90fd\uff09<\/li>\n
        6. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c116\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u5968\u52b1\u8cde\u53d7\u8cde\u8a18\u5ff5\u8b1b\u6f14\uff0c\u201cTumor endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan\u201d\uff0c2017.10.21\uff08\u672d\u5e4c\uff09<\/li>\n
        7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c76\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1aInternational Sessions\u300c\u304c\u3093\u8ee2\u79fb\u306b\u304a\u3051\u308b\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u7814\u7a76\u306e\u6700\u524d\u7dda\u300d\uff0c\u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e\u201d\uff0c2017.9.28\uff08\u6a2a\u6d5c\uff09<\/li>\n
        8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c35\u56de\u65e5\u672c\u9aa8\u4ee3\u8b1d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u5171\u50ac\u30fb\u7b2c20\u56de\u764c\u3068\u9aa8\u75c5\u5909\u7814\u7a76\u4f1a\u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u764c\u3068\u9aa8\u75c5\u5909\u300d\u201c\u816b\u760d\u8840\u7ba1\u306e\u7570\u5e38\u3068\u60aa\u6027\u5316\u201d2017. 7.29 (\u798f\u5ca1)<\/li>\n
        9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c26\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02\u300c\u304c\u3093\u5e79\u7d30\u80de\u306b\u5bfe\u3059\u308b\u65b0\u305f\u306a\u77e5\u898b\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u304c\u3093\u5e79\u7d30\u80de\u3078\u306e\u95a2\u4e0e\u201d\uff0c2017.7.28\uff08\u5927\u962a\uff09<\/li>\n
        10. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u611b\u5a9b\u5927\u5b66\u30d7\u30ed\u30c6\u30aa\u30b5\u30a4\u30a8\u30f3\u30b9\u30bb\u30f3\u30bf\u30fc\u3000PROS\u30bb\u30df\u30ca\u30fc&\u5927\u5b66\u9662\u7279\u5225\u8b1b\u7fa9\u3000\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c2017.6.12 \u00a0(\u611b\u5a9b)<\/li>\n<\/ol>\n

          \u56fd\u969b\u5b66\u4f1a\u767a\u8868<\/h4>\n
            \n
          1. Maishi N.,\u00a0Hida K<\/u>.\uff1aTumor endothelial cells in high metastatic tumors promote metastasis via biglycan, Protein Island Matsuyama 2017 International Symposium (PIM 2017), 2017.9.13 (Matsuyama, Japan)<\/li>\n
          2. Kikuchi H., Maishi N., Akiyama K., Morimoto M., Yanagiya M., Miyajima N., Tsuchiya K., Maruyama S., Abe T., Hida Y., Harabayashi T., Ameda K., Matsumoto R., Kashiwagi A., Matsuno Y., Shinohara N.,\u00a0Hida K.<\/u>,\uff1aAnalysis of multidrug resistant transporter expression in tumor blood vessels of urothelial carcinoma during chemotherapy, 2017 ASCO Annual Meeting, 2017. 6. 2-6, Chicago, Illinois<\/li>\n<\/ol>\n

            \u56fd\u5185\u5b66\u4f1a\u767a\u8868<\/strong><\/h4>\n
              \n
            1. Dorcas A. Annan, Maishi N., Soga T., Randa Dawood, Hida Y. and\u00a0Hida K<\/u>.\uff1aGlutamine Metabolism in Tumor Endothelial Cells\uff0c\u7b2c8\u56deIGM\u7814\u7a76\u4ea4\u6d41\u4f1a\uff0c2017.12.20\uff08\u672d\u5e4c\uff09<\/li>\n
            2. \u4f50\u85e4\u771f\u73e0\u7f8e\uff0c\u83ca\u5730\u3000\u592e\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u9ad8\u5009\u4f38\u5e78\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u6297\u764c\u5264\u6cbb\u7642\u304c\u816b\u760d\u8840\u7ba1\u3068\u304c\u3093\u5e79\u7d30\u80de\u306b\u53ca\u307c\u3059\u5f71\u97ff\uff0c\u7b2c8\u56deIGM\u7814\u7a76\u4ea4\u6d41\u4f1a\uff0c2017.12.20\uff08\u672d\u5e4c\uff09<\/li>\n
            3. \u68ee\u672c\u771f\u5f18\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u83ca\u5730\u3000\u592e\uff0c\u5317\u5ddd\u5584\u653f\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u7531\u6765\u30a8\u30af\u30bd\u30bd\u30fc\u30e0miRNA\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306e\u5f62\u8cea\u5909\u5316\u3068\u8ee2\u79fb\u4fc3\u9032\uff0c\u7b2c8\u56deIGM\u7814\u7a76\u4ea4\u6d41\u4f1a\uff0c2017.12.20\uff08\u672d\u5e4c\uff09<\/li>\n
            4. \u68ee\u672c\u6d69\u53f2\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u897f\u539f\u5e83\u53f2\uff0c\u7551\u4e2d\u3000\u8c4a\uff0c\u677e\u91ce\u5409\u5b8f\uff0c\u4e2d\u6751\u3000\u900f\uff0c\u5e73\u91ce\u3000\u8061\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u80ba\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u30de\u30fc\u30ab\u30fcbiglyca\u306e\u767a\u73fe\u89e3\u6790\uff0c\u7b2c8\u56deIGM\u7814\u7a76\u4ea4\u6d41\u4f1a\uff0c2017.12.20\uff08\u672d\u5e4c\uff09<\/li>\n
            5. \u9593\u77f3\u5948\u6e56\uff0c\u83ca\u5730\u3000\u592e\uff0cMohammad Towfik Alam\uff0cRanda Ibrahim Hassan Dawood\uff0c\u6b66\u7530\u3000\u907c\uff0c\u77f3\u585a\u5553\u592a\uff0c\u677e\u672c\u9686\u5150\uff0c\u79cb\u91ce\u6587\u81e3\uff0c\u571f\u5c4b\u90a6\u5f66\uff0c\u5b89\u90e8\u5d07\u91cd\uff0c\u5927\u6fa4\u5d07\u5b8f\uff0c\u5bae\u5cf6\u3000\u76f4\u4eba\uff0c\u4e38\u5c71\u3000\u899a\uff0c\u539f\u6797\u3000\u900f\uff0c\u5c71\u57ce\u52dd\u91cd\uff0c\u98f4\u7530\u3000\u8981\uff0c\u67cf\u6728\u3000\u660e\uff0c\u677e\u91ce\u5409\u5b8f\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u7be0\u539f\u4fe1\u96c4\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5c3f\u8def\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u6297\u304c\u3093\u5264\u6cbb\u7642\u304c\u3082\u305f\u3089\u3059\u816b\u760d\u8840\u7ba1\u306e\u8010\u6027\u7372\u5f97\uff0c\u7b2c8\u56deIGM\u7814\u7a76\u4ea4\u6d41\u4f1a\uff0c2017.12.20\uff08\u672d\u5e4c\uff09<\/li>\n
            6. \u68ee\u672c\u6d69\u53f2\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u897f\u539f\u5e83\u53f2\uff0c\u7551\u4e2d\u3000\u8c4a\uff0c\u677e\u91ce\u5409\u5b8f\uff0c\u5e73\u91ce\u3000\u8061\uff0c\u6a0b\u7530\u4eac\u5b50\uff1a\u80ba\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u30de\u30fc\u30ab\u30fcbiglycan\u306e\u767a\u73fe\u89e3\u6790, \u7b2c116\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u4f8b\u4f1a\uff0c2017.10.21\uff08\u672d\u5e4c\uff09<\/li>\n
            7. Dorcas A.Annan,\u3000\u9593\u77f3\u5948\u6e56\uff0c\u66fd\u6211\u670b\u7fa9\uff0cDawood Randa, \u6a0b\u7530\u6cf0\u6d69\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1aGlutamine Metabolism in Tumor Endothelial Cells, \u7b2c116\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u4f8b\u4f1a\uff0c2017.10.21\uff08\u672d\u5e4c\uff09<\/li>\n
            8. Dorcas A.Annan, Maishi N., Soga T., Randa Dawood, Hida Y.,\u00a0Hida K.<\/u>\uff1aGlutamine Metabolism in Tumor Endothelial Cells, \u7b2c76\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c2017.9.30\uff08\u6a2a\u6d5c\uff09<\/li>\n
            9. \u9593\u77f3\u5948\u6e56\uff0c\u83ca\u5730\u3000\u592e\uff0c\u68ee\u672c\u6d69\u53f2\uff0c\u571f\u5c4b\u90a6\u5f66\uff0c\u5b89\u90e8\u5d07\u91cd\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u539f\u6797\u3000\u900f\uff0c\u677e\u91ce\u5409\u5b8f\uff0c\u7be0\u539f\u4fe1\u96c4\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c76\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c2017.9.29\uff08\u6a2a\u6d5c\uff09<\/li>\n
            10. \u68ee\u672c\u6d69\u53f2\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u897f\u539f\u5e83\u53f2\uff0c\u7551\u4e2d\u3000\u8c4a\uff0c\u677e\u91ce\u5409\u5b8f\uff0c\u4e2d\u6751\u3000\u900f\uff0c\u5e73\u91ce\u3000\u8061\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u80ba\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u30de\u30fc\u30ab\u30fcbiglycan\u306e\u767a\u73fe\u89e3\u6790\uff0c\u7b2c76\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c2017.9.29\uff08\u6a2a\u6d5c\uff09<\/li>\n
            11. \u68ee\u672c\u771f\u5f18, \u9593\u77f3\u5948\u6e56,\u00a0\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u7531\u6765\u30a8\u30af\u30bd\u30bd\u30fc\u30e0miRNA\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306e\u85ac\u5264\u8010\u6027\u8a98\u5c0e, \u7b2c59\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a, 2017.9.16\uff08\u677e\u672c\uff09<\/li>\n
            12. \u6b66\u7530\u3000\u907c\uff0c\u68ee\u672c\u771f\u5f18\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u6297\u764c\u5264\u6cbb\u7642\u306b\u3088\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u85ac\u5264\u8010\u6027\u7372\u5f97\u6a5f\u69cb, \u7b2c59\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a, 2017.9.16\uff08\u677e\u672c\uff09<\/li>\n
            13. \u9593\u77f3\u5948\u6e56, \u9ce5\u5c45\u3061\u3055\u307b, \u5ddd\u672c\u6cf0\u8f14, \u68ee\u672c\u771f\u5f18, \u79cb\u5c71\u5ee3\u8f14, \u5409\u5ca1\u7950\u4eae, Alam Mohammad Towfik, \u5357\u3000\u656c, \u843d\u8c37\u5b5d\u5e83, \u6a0b\u7530\u6cf0\u6d69,\u00a0\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u9ad8\u8ee2\u79fb\u6027\u816b\u760dmiR\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e, \u7b2c26\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c2017.7.28\uff08\u5927\u962a\uff09<\/li>\n
            14. \u83ca\u5730\u3000\u592e, \u9593\u77f3\u5948\u6e56, \u79cb\u5c71\u5ee3\u8f14, \u68ee\u672c\u771f\u5f18, \u571f\u5c4b\u90a6\u5f66, \u4e38\u5c71\u3000\u899a, \u5b89\u90e8\u5d07\u91cd, \u6a0b\u7530\u3000\u6cf0\u6d69, \u539f\u6797\u3000\u900f, \u98f4\u7530\u3000\u8981, \u677e\u672c\u9686\u5150, \u67cf\u6728\u3000\u660e, \u677e\u91ce\u5409\u5b8f, \u7be0\u539f\u4fe1\u96c4,\u00a0\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5c3f\u8def\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u6297\u764c\u5264\u6cbb\u7642\u5f8c\u306e\u816b\u760d\u8840\u7ba1ABCB1\u767a\u73fe\u4ea2\u9032\uff0c\u7b2c26\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c2017.7.28(\u5927\u962a\uff09<\/li>\n
            15. \u68ee\u672c\u6d69\u53f2, \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u6cf0\u6d69, \u897f\u539f\u5e83\u53f2, \u7551\u4e2d\u3000\u8c4a, \u677e\u91ce\u5409\u5b8f, \u4e2d\u6751\u3000\u900f, \u5e73\u91ce\u3000\u8061,\u00a0\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u80ba\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u30de\u30fc\u30ab\u30fcbiglycan\u306e\u767a\u73fe\u89e3\u6790, \u7b2c26\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c2017.7.28\uff08\u5927\u962a\uff09<\/li>\n
            16. Randa Ibrahim Dawood, Yanagiya M., Maishi N., Hida Y., Torii C., Kikuchi H., Ohga N., Tei K., Kitakura T., Shindoh M.,\u00a0Hida K<\/u>.\uff1aCorrelation between endothelial CXCR7 expression and clinic pathological factors in oral squamous cell carcinoma (OSCC)\uff0c\u7b2c5\u56de\u304c\u3093\u3068\u4ee3\u8b1d\u7814\u7a76\u4f1a in \u672d\u5e4c\uff0c2017.7.14\uff08\u672d\u5e4c\uff09<\/li>\n
            17. \u68ee\u672c\u771f\u5f18\uff0c\u9ce5\u5c45\u3061\u3055\u307b\uff0c\u5ddd\u672c\u6cf0\u8f14\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u5409\u5ca1\u7950\u4eae\uff0c\u843d\u8c37\u5b5d\u5e83\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u30a8\u30af\u30bd\u30bd\u30fc\u30e0miR\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306e\u85ac\u5264\u8010\u6027\u8a98\u5c0e\uff0c\u7b2c5\u56de\u304c\u3093\u3068\u4ee3\u8b1d\u7814\u7a76\u4f1a in \u672d\u5e4c\uff0c2017.7.14\uff08\u672d\u5e4c\uff09<\/li>\n
            18. \u68ee\u672c\u6d69\u53f2\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u6cf0\u6d69\uff0c\u897f\u539f\u5e83\u53f2\uff0c\u7551\u4e2d\u3000\u8c4a\uff0c\u677e\u91ce\u5409\u5b8f\uff0c\u4e2d\u6751\u3000\u900f\uff0c\u5e73\u91ce\u3000\u8061\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1aThe analysis of biglycan expression in human lung cancer\uff0c\u7b2c5\u56de\u304c\u3093\u3068\u4ee3\u8b1d\u7814\u7a76\u4f1a in \u672d\u5e4c\uff0c2017.7.14\uff08\u672d\u5e4c\uff09<\/li>\n
            19. \u83ca\u5730\u3000\u592e, \u9593\u77f3\u5948\u6e56, \u79cb\u5c71\u5ee3\u8f14, Randa Ibrahim Hassan Dawood, \u571f\u5c4b\u90a6\u5f66, \u4e38\u5c71\u3000\u899a, \u5b89\u90e8\u5d07\u91cd, \u6a0b\u7530\u6cf0\u6d69\uff0c\u539f\u6797\u3000\u900f, \u98f4\u7530\u3000\u8981, \u67cf\u6728\u3000\u660e, \u677e\u91ce\u5409\u5b8f, \u7be0\u539f\u4fe1\u96c4,\u00a0\u6a0b\u7530\u4eac\u5b50<\/u>\uff1aAnalysis of multidrug resistant transporter expression in tumor blood vessels of urothelial carcinoma during chemotherapy\uff0c\u7b2c5\u56de\u304c\u3093\u3068\u4ee3\u8b1d\u7814\u7a76\u4f1a in \u672d\u5e4c\uff0c2017.7.14\uff08\u672d\u5e4c\uff09<\/li>\n
            20. Dorcas A. Annan, Maishi N., Soga T., Hojo T., Randa Dawood, Hida Y., Kikuchi H.,\u00a0Hida K.<\/u>\uff1aTumor endothelial cells tolerate low pH environments by upregulating proton transporters\uff0c\u7b2c5\u56de\u304c\u3093\u3068\u4ee3\u8b1d\u7814\u7a76\u4f1a in \u672d\u5e4c\uff0c2017.7.13\uff08\u672d\u5e4c\uff09<\/li>\n
            21. \u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308bBiglycan\u306e\u5206\u6ccc\u3092\u4ecb\u3057\u305f\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032\uff0c\u7b2c\uff12\u56de\u53e3\u8154\u533b\u79d1\u5b66\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\u7814\u7a76\u4f1a\uff0c2017.3.5\uff08\u5c71\u5f62\uff09<\/li>\n
            22. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5e73\u621028\u5e74\u5ea6\u91d1\u6ca2\u5927\u5b66\u304c\u3093\u9032\u5c55\u5236\u5fa1\u7814\u7a76\u6240\u5171\u540c\u5229\u7528\u30fb\u5171\u540c\u7814\u7a76\u62e0\u70b9\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c\u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760dmiR\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e\u201d\uff0c2017.2.14\uff08\u91d1\u6ca2)<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

              \u7dcf\u8aac\u30fb\u8457\u66f8\uff08\u65e5\u672c\u8a9e\uff09 \u6a0b\u7530\u4eac\u5b50\uff0c\u9593\u77f3\u5948\u6e56\uff0c\u68ee\u672c\u771f\u5f18\uff1a\u843d\u8c37\u5b5d\u5e83\u76e3\u4fee\uff0c\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\u3092\u3082\u305f\u3089\u3059\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u6a5f\u80fd\u7814\u7a76\u6700\u524d\u7dda\uff0c\u201c\u304c\u3093\u3068\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u201d\uff0c\u30a8\u30cc\u30fb\u30c6\u30a3\u30fc\u30fb\u30a8\u30b9\uff0c127-136, 2017\uff08\u5206\u62c5\u57f7\u7b46\uff09 \u6a0b\u7530\u4eac\u5b50, \u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u7cfb\u306e\u7570\u5e38,\u300c\u751f\u4f53\u306e\u79d1\u5b66 \u7279\u96c6 \u8840\u7ba1\u5236\u5fa1\u7cfb\u3068\u75be\u60a3\u300d\u533b\u5b66\u66f8\u9662, 68(4), 321\u2212323, 2017 \u82f1\u6587\u7dcf\u8aac *Hida K., Maishi N….\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":18,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-159","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/comments?post=159"}],"version-history":[{"count":6,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/159\/revisions"}],"predecessor-version":[{"id":800,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/159\/revisions\/800"}],"up":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/18"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/media?parent=159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}